Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Novo Nordisk claims xanomeline as potential urinary bladder disorder treatment

July 26, 1996

Positive results in trial of Cystistat in refractory interstitial cystitis patients

July 19, 1996

CGP-53153: Ciba-Geigy's steroidal 5alpha-reductase inhibitor as BPH therapy

July 19, 1996

Glaxo Wellcome describes alpha1A-adrenoceptor antagonists

July 19, 1996

Cystistat covered under U.S. patent

July 12, 1996

5alpha-Reductase inhibitors from Kyowa Hakko

July 12, 1996

Selective alpha1A-adrenoceptor antagonists with multiple indications

July 12, 1996

Flutamide BPH trial results reported

July 5, 1996

Abbott reports alpha1-antagonists for BPH

July 5, 1996

Human Genome Sciences discloses polypeptide research

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...